naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution [Naphcon A]
RxNorm concept 1046266, branded drug (sbd). Prescribable name: NAPHCON A 0.025 % / 0.3 % Ophthalmic Solution.
- RxCUI
- 1046266
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Naphcon A (naphazoline HCl 0.025 % / pheniramine maleate 0.3 % ) Ophthalmic Solution; Naphcon A 0.025 % / 0.3 % Ophthalmic Solution
Related concepts
- naphazoline hydrochloride 0.25 MG/ML (SCDC, consists of)
- pheniramine maleate 3 MG/ML (SCDC, consists of)
- naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML [Naphcon A] (SBDC, consists of)
- Ophthalmic Solution (DF, has dose form)
- Naphcon A (BN, has ingredient)
- naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution (SCD, tradename of)
Linked data
NDCs
- 00065008515
- 00065008542
- 00065008552
- 00247108415
- 50090018500
- 50090716500
- 52959010703
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1046266 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1046266. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.